| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db299197d01ed3e018d63d3f30cc1d80 |
| publicationDate |
2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005020489-A1 |
| titleOfInvention |
Use of hcg and lh in controlled ovarian hyperstimulation |
| abstract |
The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG or LH, or a bio-analogue thereof, is administered during the follicular phase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016135221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014159813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020352962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413592-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11351228-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9579305-B2 |
| priorityDate |
2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |